These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29497709)

  • 1. A Protective Role for NKG2D-H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune Diabetes Pathogenesis.
    Trembath AP; Sharma N; Raju S; Polić B; Markiewicz MA
    Immunohorizons; 2017 Nov; 1(9):198-212. PubMed ID: 29497709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKG2D Signaling Within the Pancreatic Islets Reduces NOD Diabetes and Increases Protective Central Memory CD8
    Trembath AP; Krausz KL; Sharma N; Gerling IC; Mathews CE; Markiewicz MA
    Diabetes; 2020 Aug; 69(8):1749-1762. PubMed ID: 32535552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.
    Amrani A; Verdaguer J; Anderson B; Utsugi T; Bou S; Santamaria P
    J Clin Invest; 1999 Apr; 103(8):1201-9. PubMed ID: 10207172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes.
    Van Belle TL; Ling E; Haase C; Bresson D; Ursø B; von Herrath MG
    J Autoimmun; 2013 Feb; 40():66-73. PubMed ID: 22944096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2D blockade prevents autoimmune diabetes in NOD mice.
    Ogasawara K; Hamerman JA; Ehrlich LR; Bour-Jordan H; Santamaria P; Bluestone JA; Lanier LL
    Immunity; 2004 Jun; 20(6):757-67. PubMed ID: 15189740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
    J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
    J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ CD122+ PD-1- effector cells promote the development of diabetes in NOD mice.
    Arndt B; Witkowski L; Ellwart J; Seissler J
    J Leukoc Biol; 2015 Jan; 97(1):111-20. PubMed ID: 25387835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice].
    Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice.
    Nagata M; Santamaria P; Kawamura T; Utsugi T; Yoon JW
    J Immunol; 1994 Feb; 152(4):2042-50. PubMed ID: 7907110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
    J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D stimulation of CD8
    Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
    Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
    Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
    J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice.
    Xia J; Liu W; Hu B; Tian Z; Yang Y
    Clin Immunol; 2010 Feb; 134(2):130-9. PubMed ID: 19875339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
    Kim D; Kim JY; Jun HS
    Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.